Pharmacological effects of berberine on mood disorders

被引：67
|
作者：
Fan, Jie [1 ]
Zhang, Kun [1 ]
Jin, Yang [1 ]
Li, Bingjini [1 ]
Gao, Shuohui [2 ]
Zhu, Jiaming [1 ]
Cui, Ranji [1 ]
机构：
[1] Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Hosp 2, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Dept Gastrointestinal Colorectal Surg, China Japan Union Hosp, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2019年 / 23卷 / 01期
关键词：
anxiety; berberine; bipolar disorder; depression; mechanism; pharmacology; ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; STAR-ASTERISK-D; NF-KAPPA-B; SIGMA-1; RECEPTORS; IN-VITRO; ISOQUINOLINE ALKALOIDS; MAJOR DEPRESSION; PC12; CELLS; RAT MODEL;
D O I：
10.1111/jcmm.13930
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Berberine, a natural isoquinoline alkaloid, is used in herbal medicine and has recently been shown to have efficacy in the treatment of mood disorders. Furthermore, berberine modulates neurotransmitters and their receptor systems within the central nervous system. However, the detailed mechanisms of its action remain unclear. This review summarizes the pharmacological effects of berberine on mood disorders. Therefore, it may be helpful for potential application in the treatment of mood disorders.
引用
收藏
页码：21 / 28
页数：8
相关论文
共 50 条
  • [21] PSYCHOTIC SYMPTOMS IN MOOD DISORDERS: A BRIEF REVIEW OF CLINICAL AND PHARMACOLOGICAL ASPECTS
    Franchini, Linda
    Spagnolo, Chiara
    Fresi, Francesco
    CLINICAL NEUROPSYCHIATRY, 2005, 2 (03): : 189 - 198
  • [22] Galanin receptor antagonists -: A potential novel pharmacological treatment for mood disorders
    Ogren, Sven Ove
    Kuteeva, Eugenia
    Hokfelt, Tomas
    Kehr, Jan
    CNS DRUGS, 2006, 20 (08) : 633 - 654
  • [23] Large-scale suicide prevention by pharmacological treatment of mood disorders
    Isometsa, E.
    EUROPEAN PSYCHIATRY, 2016, 33 : S53 - S53
  • [24] Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
    Li, Xiaohua
    Frye, Mark A.
    Shelton, Richard C.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 77 - 101
  • [25] Galanin receptor antagonists: A potential novel pharmacological treatment for mood disorders
    Ögren S.O.
    Kuteeva E.
    Ḧokfelt T.
    Kehr J.
    CNS Drugs, 2006, 20 (8) : 633 - 654
  • [26] Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
    Xiaohua Li
    Mark A Frye
    Richard C Shelton
    Neuropsychopharmacology, 2012, 37 : 77 - 101
  • [27] Mood Disorders And Their Pharmacological Treatment During Pregnancy: Is the Future Child Affected?
    Monk, Catherine
    Fitelson, Elizabeth M.
    Werner, Elizabeth
    PEDIATRIC RESEARCH, 2011, 69 (05) : 3R - 10R
  • [28] Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide
    Sondergard, Lars
    Lopez, Ana Garcia
    Andersen, Per Kragh
    Kessing, Lars Vedel
    BIPOLAR DISORDERS, 2008, 10 (01) : 87 - 94
  • [29] LOCALISATION OF β-CATENIN IN THE ADULT BRAIN: A PUTATIVE PHARMACOLOGICAL TARGET IN MOOD DISORDERS
    Pascual-Brazo, J.
    Pazos, A.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 83 - 83
  • [30] Mood Disorders And Their Pharmacological Treatment During Pregnancy: Is the Future Child Affected?
    Catherine Monk
    Elizabeth M Fitelson
    Elizabeth Werner
    Pediatric Research, 2011, 69 : 3 - 10
12345